Get the Stockscreener App
2.93
1.93%
0.08
Collplant Biotechnologies Ltd stock is traded at $2.93, with a volume of 12,066.
It is up +1.93% in the last 24 hours and up +101.74% over the past month.
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.
See More
Previous Close:
$2.85
Open:
$2.83
24h Volume:
12,066
Relative Volume:
0.11
Market Cap:
$36.94M
Revenue:
$10.96M
Net Income/Loss:
$-7.02M
P/E Ratio:
-4.5781
EPS:
-0.64
Net Cash Flow:
$-3.72M
1W Performance:
+29.23%
1M Performance:
+101.74%
6M Performance:
-18.17%
1Y Performance:
-35.15%
1-Day Range:
$2.6909
$2.95
1-Week Range:
$2.14
$2.9682
52-Week Range:
$1.31
$5.45
Collplant Biotechnologies Ltd Stock (CLGN) Company Profile
Name
Collplant Biotechnologies Ltd
Sector
Industry
Phone
-
Address
-
Compare CLGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLGN
Collplant Biotechnologies Ltd
|
2.905 | 35.22M | 10.96M | -7.02M | -3.72M | -0.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
376.83 | 93.98B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.13 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
443.52 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
645.97 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.45 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Collplant Biotechnologies Ltd Stock (CLGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-17-23 | Initiated | Alliance Global Partners | Buy |
Collplant Biotechnologies Ltd Stock (CLGN) Latest News
Can trapped investors hope for a rebound in CollPlant Biotechnologies Ltd.AI Powered Stock Trend Prediction Model - Newser
Intraday pattern recognizer results for CollPlant Biotechnologies Ltd.Short-Term Growth Watch with Signal Prediction - Newser
Using fundamentals and technicals on CollPlant Biotechnologies Ltd.Predictable Income Summary for Long-Term Trades - Newser
Evaluating CollPlant Biotechnologies Ltd. with trendline analysisEntry and Exit Strategy for Swing Traders - Newser
Will breakout in CollPlant Biotechnologies Ltd. lead to full recoveryFree Alert Feed for Momentum Based Picks - Newser
Using Python tools to backtest CollPlant Biotechnologies Ltd. strategiesIntraday Signal Forecast for Fast Traders - Newser
What does recent volatility data suggest for CollPlant Biotechnologies Ltd.Automated AI Forecast with Trading Alerts - Newser
Why CollPlant Biotechnologies Ltd. is moving todaySecure Trading Strategy Based on Technical Analysis - Newser
Backtesting results for CollPlant Biotechnologies Ltd. trading strategiesStrong Buy Signal Summary with Entry Zone - Newser
What data driven models say about CollPlant Biotechnologies Ltd.’s futureSmart Trend Analysis With Buy Point Cues - Newser
Published on: 2025-08-10 20:18:30 - Newser
CollPlant Biotechnologies Ltd. stock volume spike explainedMulti-Year Investment Performance Summary Report - Newser
Will a bounce in CollPlant Biotechnologies Ltd. offer an exitRisk-Managed Swing Setup and Signal Analysis - Newser
Using portfolio simulators with CollPlant Biotechnologies Ltd. includedWeekly Setup Summary for Risk Controlled Trades - Newser
Analyzing drawdowns of CollPlant Biotechnologies Ltd. with statistical toolsRisk Aware Trading Ideas with Alert Levels - Newser
How CollPlant Biotechnologies Ltd. stock performs during market volatilityCapital Growth Summary Over Five Years - Newser
Why CollPlant Biotechnologies Ltd. stock attracts strong analyst attentionStrategy Chart for Real-Time Trade Flow - Newser
Exit strategy if you’re trapped in CollPlant Biotechnologies Ltd.Free High Growth Low Risk Stock Selection - Newser
How to track smart money flows in CollPlant Biotechnologies Ltd.Market Liquidity and Price Flow Analysis - Newser
Does CollPlant Biotechnologies Ltd. show high probability of reboundIntraday Movement Recap and Chart Summary - Newser
Trend analysis for CollPlant Biotechnologies Ltd. this weekFree Entry Alert Based on Volume Spikes - Newser
Should you wait for a breakout in CollPlant Biotechnologies Ltd.Swing Trade Timing with Daily Forecast - Newser
Is CollPlant Biotechnologies Ltd. trending in predictive chart modelsFree Buy Low Sell High Stock Watch - Newser
Using AI based signals to follow CollPlant Biotechnologies Ltd.AI Entry Timing Prediction for Swing Traders - Newser
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR SECOND QUARTER FINANCIAL RESULTS - Seeking Alpha
Can CollPlant Biotechnologies Ltd. recover in the next quarterStock Holding Strategy Long-Term Summary Sheet - Newser
Collplant Biotechnologies Ltd Stock (CLGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.52%
0.80%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):